Loading compound...

Cyclophilin A inhibitor

Alisporivir is a protein-type molecule being researched for its ability to inhibit Cyclophilin A. While it has been studied for various conditions, it is primarily investigated for its potential use in treating Hepatitis C and COVID-19.

How it worksAlisporivir works by blocking a protein called Cyclophilin A.

Used for
Hepatitis C virus infectionChronic hepatitis C virus infectionLiver diseaseCOVID-19Chronic kidney disease
Conditions
Hepatitis C virus infectionChronic hepatitis C virus infectionLiver diseaseCOVID-19Chronic kidney disease
Class
Cyclophilin A inhibitor

How to take

Alisporivir is currently in clinical development phases and is not a standard approved treatment for these conditions according to the provided data.

Talk to your doctor

Questions to ask

  • ·Is Alisporivir appropriate for my specific type of Hepatitis C?
  • ·What are the potential risks of Cyclophilin A inhibitors?
  • ·How does Alisporivir interact with my current liver medications?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.